Calliditas Therapeutics AB Sponsored ADR EBITDA 2020-2024 | CALT
Calliditas Therapeutics AB Sponsored ADR ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Calliditas Therapeutics AB Sponsored ADR Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-31 |
| 2022 | $-42 |
| 2021 | $-61 |
| 2020 | $-41 |
| 2019 | $-3 |
| Calliditas Therapeutics AB Sponsored ADR Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-3 |
| 2024-03-31 | $-20 |
| 2023-12-31 | $4 |
| 2023-09-30 | $-15 |
| 2023-06-30 | $-7 |
| 2023-03-31 | $-17 |
| 2022-12-31 | $5 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-21 |
| 2022-03-31 | $-22 |
| 2021-12-31 | $-25 |
| 2021-09-30 | $1 |
| 2021-06-30 | $-19 |
| 2021-03-31 | $-18 |
| 2020-12-31 | $-15 |
| 2020-09-30 | $-12 |
| 2020-06-30 | $-7 |
| 2020-03-31 | $-7 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $9 |
| 2019-03-31 | $-5 |
